Lantheus Holdings Incorporated (NASDAQ:LNTH) Sellers Covered 1.51% of Their Shorts

December 31, 2017 - By Nellie Frank

 Lantheus Holdings Incorporated (NASDAQ:LNTH) Sellers Covered 1.51% of Their Shorts

The stock of Lantheus Holdings Incorporated (NASDAQ:LNTH) registered a decrease of 1.51% in short interest. LNTH’s total short interest was 755,100 shares in December as published by FINRA. Its down 1.51% from 766,700 shares, reported previously. With 323,700 shares average volume, it will take short sellers 2 days to cover their LNTH’s short positions. The short interest to Lantheus Holdings Incorporated’s float is 4.03%.

The stock decreased 3.31% or $0.7 during the last trading session, reaching $20.45. About 376,543 shares traded. Lantheus Holdings, Inc. (NASDAQ:LNTH) has risen 644.29% since December 31, 2016 and is uptrending. It has outperformed by 627.59% the S&P500.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic medical imaging agents and products for the diagnosis and treatment of cardiovascular and other diseases worldwide. The company has market cap of $767.00 million. The Company’s principal products include DEFINITY, an ultrasound contrast imaging agent for use in patients with suboptimal echocardiograms; TechneLite, a self-contained system or generator of technetium used by radiopharmacies to prepare various nuclear imaging agents; and Xenon, a radiopharmaceutical gas used to assess pulmonary function and imaging of cerebral blood flow. It has a 25.59 P/E ratio. The firm also offers injectable technetium-labeled imaging agents, including Cardiolite, used in myocardial perfusion imaging procedures; and Neurolite, which is used to identify the area in the brain where blood flow has been blocked or reduced due to stroke.

Lantheus Holdings, Inc. (NASDAQ:LNTH) Ratings Coverage

Among 6 analysts covering Lantheus Holdings (NASDAQ:LNTH), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Lantheus Holdings had 16 analyst reports since August 31, 2015 according to SRatingsIntel. The firm has “Neutral” rating by Credit Suisse given on Friday, December 11. The rating was upgraded by Wells Fargo on Thursday, November 2 to “Buy”. The firm has “Market Perform” rating by Wells Fargo given on Wednesday, September 30. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) earned “Neutral” rating by Credit Suisse on Wednesday, August 2. The firm has “Neutral” rating by Robert W. Baird given on Monday, August 31. Jefferies maintained Lantheus Holdings, Inc. (NASDAQ:LNTH) rating on Tuesday, October 10. Jefferies has “Buy” rating and $22.0 target. The rating was maintained by Jefferies on Monday, August 29 with “Buy”. The stock of Lantheus Holdings, Inc. (NASDAQ:LNTH) has “Neutral” rating given on Friday, September 23 by Credit Suisse. Jefferies maintained the stock with “Buy” rating in Thursday, June 29 report. Jefferies maintained Lantheus Holdings, Inc. (NASDAQ:LNTH) on Friday, November 3 with “Buy” rating.

More notable recent Lantheus Holdings, Inc. (NASDAQ:LNTH) news were published by: Fool.com which released: “Why Lantheus Holdings Inc. Got Smacked Down Today” on March 14, 2017, also Businesswire.com with their article: “Lantheus Holdings, Inc. Announces Public Secondary Offering by Selling …” published on June 14, 2017, Seekingalpha.com published: “Lantheus Holdings’ (DRNA) CEO Mary Anne Heino on Q3 2017 Results – Earnings …” on November 04, 2017. More interesting news about Lantheus Holdings, Inc. (NASDAQ:LNTH) were released by: Fool.com and their article: “Why Lantheus Holdings Inc. Rocketed Today” published on May 03, 2017 as well as Businesswire.com‘s news article titled: “Lantheus Announces Refinancing of its Debt Facility” with publication date: March 30, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.